Regulatory Strategy and Independent Risk Assessment for Advanced Surgical and Aesthetic Technologies

Clarity Surgical Advisors advises executive leadership teams and founders on regulatory positioning and clinical evidence strategy across surgical robotics, oncologic and ablative platforms, plastic and reconstructive devices, aesthetic technologies, and infection control.

Led by board-certified general surgeon and former FDA Office Director who oversaw national surgical device policy, with with prior service in the White House.

She oversaw national regulatory policy and review for the same surgical technologies she has used in clinical practice, uniquely combining frontline clinical experience with federal oversight.